FN2 Earnings Intelligence

TG Therapeutics, Inc. balance sheet (quarterly)

TG Therapeutics, Inc. (TGTX) Balance Sheet (quarterly) derived from persisted SEC financial facts.

Balance Sheet

USD in millions, except per-share values and percentages.

Metric 3/31/20256/30/20259/30/20253/31/20269/30/2026
Cash & Equivalents $132.1$129.1$74.1$442.2$429.4
Short-term Debt -----
Long-term Debt $244.7$245$245.3$745.1$745.6
Total Debt -----

Get the TGTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.